SCHEDULE 13G
Statement of Beneficial Ownership
NEKTAR THERAPEUTICS Filed Acc 0001104659-25-078723
Stakes reported in this filing
Stake history · largest stake in each 13D and 13G
- 2026-11-10 SCHEDULE 13G · STATE STREET CORPORATION 5.2%
- 2026-09-28 SCHEDULE 13G/A · Two Seas Capital LP 9.8%
- 2026-08-14 SCHEDULE 13G/A · Two Seas Capital LP 9.1%
- 2026-08-14 SCHEDULE 13G/A · BVF PARTNERS L P/IL 7.1%
- 2026-07-31 SCHEDULE 13G · Vanguard Capital Management 5.17%
- 2026-07-29 SCHEDULE 13G · BlackRock, Inc. 7.8%
- 2026-05-15 SCHEDULE 13G/A · BVF PARTNERS L P/IL 9.8%
- 2026-05-06 SCHEDULE 13G/A · FMR LLC 15.0%
- 2026-04-17 SCHEDULE 13G · Two Seas Capital LP 6.8%
- 2026-03-27 SCHEDULE 13G/A · The Vanguard Group 0%
- 2026-03-06 SCHEDULE 13G · FMR LLC 11.1%
Loading xslSCHEDULE_13G_X01/primary_doc.xml…